• Explore /
  • Poster
  • / A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.

A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.

Abstract Poster

Authors

null

Virginia Calvo

Instituto Investigacion Sanitaria Puerta de Hierro-Segovia de Arana, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain

Virginia Calvo , Manuel Domine , Ivana Sullivan , Jose-Luis Gonzalez-Larriba , Ana Laura Ortega , Reyes Bernabé , Maria Angeles Sala , Begona Campos , Javier De Castro , Paloma Martín-Martorell , Joaquim Bosch-Barrera , Xabier Mielgo , Laia Vilà , Joaquin Casal , Silver Ros , Maite Martinez Aguillo , Airam Padilla , Sergio Sandiego , Jonathan Aires Machado , Mariano Provencio-Pulla

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT04564157

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS8581)

DOI

10.1200/JCO.2021.39.15_suppl.TPS8581

Abstract #

TPS8581

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Tina Cascone

First Author: Xue-ning Yang

First Author: Yuming Zhu

First Author: Patrick M. Forde